IP Library › Assignment 055608/0382
Patent Assignment
Reel/Frame 055608/0382

Assignment of Assignor's Interest

Recorded: 2021-03-11 Pages: 8
Assignor
IONIS PHARMACEUTICALS, INC.
Executed: 2019-01-07
Assignee
BIOGEN MA INC.
225 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (5)
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 7,132,530 →
Application: 10/633,843 →
Publication: US 2004/0091919
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 7,678,895 →
Application: 11/449,207 →
Publication: US 2006/0293269
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 7,902,163 →
Application: 11/449,446 →
Publication: US 2007/0054869
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 8,993,529 →
Application: 12/987,929 →
Publication: US 2012/0029049
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 9,476,051 →
Application: 14/630,581 →
Publication: US 2015/0167008
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jun 15, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 042821/0921 →
Change of Name Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0420 →
Change of Name Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0481 →
Change of Name Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0571 →